Mattle H - Search Results

1

Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents.

Pilgrim T, Kalesan B, Zanchin T, Pulver C, Jung S, Mattle H, Carrel T, Moschovitis A, Stortecky S, Wenaweser P, Stefanini GG, Räber L, Meier B, Jüni P, Windecker S. Pilgrim T, et al. Among authors: mattle h. EuroIntervention. 2013 Jan 22;8(9):1061-71. doi: 10.4244/EIJV8I9A163. EuroIntervention. 2013. PMID: 23339812 Free article.

2

Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism.

Wahl A, Meier B, Haxel B, Nedeltchev K, Arnold M, Eicher E, Sturzenegger M, Seiler C, Mattle HP, Windecker S. Wahl A, et al. Among authors: mattle hp. Neurology. 2001 Oct 9;57(7):1330-2. doi: 10.1212/wnl.57.7.1330. Neurology. 2001. PMID: 11591862

3

Outcome of patients with cryptogenic stroke and patent foramen ovale.

Nedeltchev K, Arnold M, Wahl A, Sturzenegger M, Vella EE, Windecker S, Meier B, Mattle HP. Nedeltchev K, et al. Among authors: mattle hp. J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):347-50. doi: 10.1136/jnnp.72.3.347. J Neurol Neurosurg Psychiatry. 2002. PMID: 11861693 Free PMC article.

4

Long-term outcome after stroke due to atrial fibrillation.

Mattle HP. Mattle HP. Cerebrovasc Dis. 2003;16 Suppl 1:3-8. doi: 10.1159/000069934. Cerebrovasc Dis. 2003. PMID: 12698012 Review.

5

[Atrial fibrillation and stroke].

Mattle HP, Schwerzmann M, Seiler Ch. Mattle HP, et al. Ther Umsch. 2003 Sep;60(9):527-34. doi: 10.1024/0040-5930.60.9.527. Ther Umsch. 2003. PMID: 14579621 Review. German.

6

Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy.

Schwerzmann M, Windecker S, Wahl A, Mehta H, Nedeltchev K, Mattle H, Seiler C, Meier B. Schwerzmann M, et al. Among authors: mattle h. Heart. 2004 Feb;90(2):186-90. doi: 10.1136/hrt.2002.003111. Heart. 2004. PMID: 14729794 Free PMC article. Clinical Trial.

7

Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks.

Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, Meier B, Windecker S. Schwerzmann M, et al. Among authors: mattle hp. Neurology. 2004 Apr 27;62(8):1399-401. doi: 10.1212/01.wnl.0000120677.64217.a9. Neurology. 2004. PMID: 15111681

8

Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.

Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Windecker S, et al. J Am Coll Cardiol. 2004 Aug 18;44(4):750-8. doi: 10.1016/j.jacc.2004.05.044. J Am Coll Cardiol. 2004. PMID: 15312853 Free article.

9

Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale.

Schwerzmann M, Windecker S, Wahl A, Nedeltchev K, Mattle HP, Seiler C, Meier B. Schwerzmann M, et al. Catheter Cardiovasc Interv. 2004 Dec;63(4):490-5. doi: 10.1002/ccd.20221. Catheter Cardiovasc Interv. 2004. PMID: 15558761

10

Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Mattle HP, Meier B, Windecker S; PC Trial Group. Mattle HP, et al. Neurology. 2004 Dec 14;63(11):2198-9; author reply 2198-9. Neurology. 2004. PMID: 15602809 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

441 results

Search Page